COVID-19 Task Force Speaker Prof Wiku Adisasmito. Photo: HO / BNPB
jpnn.com, JAKARTA – The COVID-19 Handling Task Force stated that it would be open to providing the COVID-19 vaccine from any company, as long as it was scientifically tested and passed all procedures from the Food and Drug Supervisory Agency (BPOM).
“The point is that the government is open to any vaccine candidate, without being careless in deciding to cooperate, because the determination of this vaccine candidate must go through an escort process by the BPOM and be studied with scientific basics,” said Wiku Adisasmito, spokesman for the COVID-19 Handling Task Force during the teleconference. press in Jakarta, Tuesday (17/11).
Wiku said that the vaccines that the Indonesian government would later use were confirmed to have passed phase one, two and three clinical trials, and obtained authorization for emergency use from the BPOM.
In addition, the vaccines that will be selected will also be confirmed according to the characteristics of the community and suitable with the conditions of facilities and infrastructure in the country.
“In accordance with other supporting facilities such as cold chains,” said Wiku.
Earlier in the last few weeks, two vaccine candidates from two pharmaceutical companies claimed to have an effectiveness rate of warding off COVID-19 by up to 90 percent.
US-based pharmaceutical corporation Moderna claims the experimental vaccine it has developed is 94.5 percent effective at preventing COVID-19 based on preliminary data from the final stage of trials.
Then, the vaccine from Pfizer, a US company that partners with BioNTech, a German company, also claims to have succeeded in preventing viral infections by up to 90 percent.